Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
to improve people's health in developing countries by striving for excellence in research, healthcare, and training. Our research program spans basic scientific research, clinical studies, epidemiological
-
for yield management through ensuring London Business School remains engaged with applicants from the point of enquiry until the point of entry to the programme on their first day, and through management
-
health researcher is sought with expertise in quantitative surveys, mathematical modeling in nutrition (especially in Sudan), and crisis clinical nutrition program management. The ideal candidate should
-
point in the future of urban studies. Applicants are also strongly encouraged therefore to consider how your programme of work will contribute to this longer-term goal. You must have a substantial
-
locally-employed laboratory personnel, ensuring all laboratory activities related to the LSHTM-COMAHS programme and ancillary and future studies are performed in strict accordance to Good Clinical
-
pay benefit, free on-site gym and wellbeing centre a comprehensive learning and development programme and support for your CPD Prospective applicants are encouraged in the first instance to contact
-
About the Role We are looking for a teaching fellow to undertake a one-year post in the school, to support the delivery of our taught postgraduate programme in Engineering Management. About You We
-
the University, in accordance with the Immigration, Asylum and Nationality Act 2006. Full-Time, Permanent Applications are invited for the post of Research Contracts and IP Manager in the Research Contracts team
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing